{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "chemotherapeutics", "immunomodulation", "multitargeting", "natural compounds"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31816878", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "24"}, "DateRevised": {"Year": "2020", "Month": "04", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "03"}], "Language": ["eng"], "ELocationID": ["4415", "10.3390/molecules24234415"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "23", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "03"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "7-<i>epi</i>-Clusianone, a Multi-Targeting Natural Product with Potential Chemotherapeutic, Immune-Modulating, and Anti-Angiogenic Properties.", "Abstract": {"AbstractText": ["Targeted therapies have changed the treatment of cancer, giving new hope to many patients in recent years. The shortcomings of targeted therapies including acquired resistance, limited susceptible patients, high cost, and high toxicities, have led to the necessity of combining these therapies with other targeted or chemotherapeutic treatments. Natural products are uniquely capable of synergizing with targeted and non-targeted anticancer regimens due to their ability to affect multiple cellular pathways simultaneously. Compounds which provide an additive effect to the often combined immune therapies and cytotoxic chemotherapies, are exceedingly rare. These compounds would however provide a strengthening bridge between the two treatment modalities, increasing their effectiveness and improving patient prognoses. In this study, 7-<i>epi</i>-clusianone was investigated for its anticancer properties. While previous studies have suggested clusianone and its conformational isomers, including 7-<i>epi</i>-clusianone, are chemotherapeutic, few cancer types have been demonstrated to exhibit sensitivity to these compounds and little is known about the mechanism. In this study, 7-<i>epi</i>-clusianone was shown to inhibit the growth of 60 cancer cell types and induce significant cell death in 25 cancer cell lines, while simultaneously modulating the immune system, inhibiting angiogenesis, and inhibiting cancer cell invasion, making it a promising lead compound for cancer drug discovery."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA."}], "LastName": "Taylor", "ForeName": "Wesley F", "Initials": "WF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA."}], "LastName": "Yanez", "ForeName": "Maria", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA."}], "LastName": "Moghadam", "ForeName": "Sara E", "Initials": "SE"}, {"Identifier": ["0000-0001-9273-1019"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran 19839-69411, Iran."}], "LastName": "Moridi Farimani", "ForeName": "Mahdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Faculty of Science, Golestan University, Gorgan 15759-49138, Iran."}], "LastName": "Soroury", "ForeName": "Sara", "Initials": "S"}, {"Identifier": ["0000-0003-2167-8032"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran 19839-69411, Iran."}], "LastName": "Ebrahimi", "ForeName": "Samad N", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran 19839-69411, Iran."}], "LastName": "Tabefam", "ForeName": "Marzieh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of South Carolina, Columbia, SC 29208, USA."}, {"Identifier": [], "Affiliation": "Biomedical Engineering Program, University of South Carolina, Columbia, SC 29208, USA."}], "LastName": "Jabbarzadeh", "ForeName": "Ehsan", "Initials": "E"}], "GrantList": [{"GrantID": "P20 GM103641", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "7-epiclusianone"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzophenones"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Benzophenones"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Benzoquinones"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}], "CoiStatement": "The authors declare no competing interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gotwals P., Cameron S., Cipolletta D., Cremasco V., Crystal A., Hewes B., Mueller B., Quaratino S., Sabatos-Peyton C., Petruzzelli L., et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat. Rev. Cancer. 2017;17:286\u2013301. doi: 10.1038/nrc.2017.17.", "ArticleIdList": ["10.1038/nrc.2017.17", "28338065"]}, {"Citation": "Heron M. Deaths: Leading Causes for 2016. Natl. Vital. Stat. Rep. 2018;67:1\u201377.", "ArticleIdList": ["30248017"]}, {"Citation": "Zugazagoitia J., Guedes C., Ponce S., Ferrer I., Molina-Pinelo S., Paz-Ares L. Current Challenges in Cancer Treatment. Clin. Ther. 2016;38:1551\u20131566. doi: 10.1016/j.clinthera.2016.03.026.", "ArticleIdList": ["10.1016/j.clinthera.2016.03.026", "27158009"]}, {"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2018. CA Cancer J. Clin. 2018;68:7\u201330. doi: 10.3322/caac.21442.", "ArticleIdList": ["10.3322/caac.21442", "29313949"]}, {"Citation": "Kimiz-Gebologlu I., Gulce-Iz S., Biray-Avci C. Monoclonal antibodies in cancer immunotherapy. Mol. Biol. Rep. 2018;45:2935\u20132940. doi: 10.1007/s11033-018-4427-x.", "ArticleIdList": ["10.1007/s11033-018-4427-x", "30311129"]}, {"Citation": "Berraondo P., Sanmamed M.F., Ochoa M.C., Etxeberria I., Aznar M.A., P\u00e9rez-Gracia J.L., Rodr\u00edguez-Ruiz M.E., Ponz-Sarvise M., Casta\u00f1\u00f3n E., Melero I. Cytokines in clinical cancer immunotherapy. Br. J. Cancer. 2018;120:6\u201315. doi: 10.1038/s41416-018-0328-y.", "ArticleIdList": ["10.1038/s41416-018-0328-y", "PMC6325155", "30413827"]}, {"Citation": "van Willigen W.W., Bloemendal M., Gerritsen W.R., Schreibelt G., de Vries I.J.M., Bol K.F. Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time. Front. Immunol. 2018;9:2265. doi: 10.3389/fimmu.2018.02265.", "ArticleIdList": ["10.3389/fimmu.2018.02265", "PMC6174277", "30327656"]}, {"Citation": "Jackson H.J., Rafiq S., Brentjens R.J. Driving CAR T-cells forward. Nat. Rev. Clin. Oncol. 2016;13:370\u2013383. doi: 10.1038/nrclinonc.2016.36.", "ArticleIdList": ["10.1038/nrclinonc.2016.36", "PMC5529102", "27000958"]}, {"Citation": "Chae Y.K., Arya A., Iams W., Cruz M.R., Chandra S., Choi J., Giles F. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC) J. Immunother. Cancer. 2018;6:39. doi: 10.1186/s40425-018-0349-3.", "ArticleIdList": ["10.1186/s40425-018-0349-3", "PMC5956851", "29769148"]}, {"Citation": "Hu R., George D.J., Zhang T. What is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence. Ther. Adv. Urol. 2016;8:272\u2013278. doi: 10.1177/1756287216645314.", "ArticleIdList": ["10.1177/1756287216645314", "PMC5131740", "27928429"]}, {"Citation": "Lin J.K., Lerman B.J., Barnes J.I., Boursiquot B.C., Tan Y.J., Robinson A.Q.L., Davis K.L., Owens D.K., Goldhaber-Fiebert J.D. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. J. Clin. Oncol. 2018;111:719\u2013726. doi: 10.1200/JCO.2018.79.0642.", "ArticleIdList": ["10.1200/JCO.2018.79.0642", "30212291"]}, {"Citation": "Liu D., Zhao J. Cytokine release syndrome: Grading, modeling, and new therapy. J. Hematol. Oncol. 2018;11:121. doi: 10.1186/s13045-018-0653-x.", "ArticleIdList": ["10.1186/s13045-018-0653-x", "PMC6154787", "30249264"]}, {"Citation": "Cogdill A.P., Andrews M.C., Wargo J.A. Hallmarks of response to immune checkpoint blockade. Br. J. Cancer. 2017;117:1\u20137. doi: 10.1038/bjc.2017.136.", "ArticleIdList": ["10.1038/bjc.2017.136", "PMC5520201", "28524159"]}, {"Citation": "Yang L., Zhang Y. Tumor-associated macrophages, potential targets for cancer treatment. Biomark. Res. 2017;5:25. doi: 10.1186/s40364-017-0106-7.", "ArticleIdList": ["10.1186/s40364-017-0106-7", "PMC5549387", "28804638"]}, {"Citation": "Lin Z., Zhang Q., Luo W. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions. Eur. J. Pharmacol. 2016;793:76\u201381. doi: 10.1016/j.ejphar.2016.10.039.", "ArticleIdList": ["10.1016/j.ejphar.2016.10.039", "27840192"]}, {"Citation": "Basmadjian C., Zhao Q., Bentouhami E., Djehal A., Nebigil C.G., Johnson R.A., Serova M., de Gramont A., Faivre S., Raymond E., et al. Cancer wars: Natural products strike back. Front. Chem. 2014;2:20. doi: 10.3389/fchem.2014.00020.", "ArticleIdList": ["10.3389/fchem.2014.00020", "PMC4013484", "24822174"]}, {"Citation": "Taylor W.F., Moghadam S.E., Moridi Farimani M., Ebrahimi S.N., Tabefam M., Jabbarzadeh E. A multi-targeting natural compound with growth inhibitory and anti-angiogenic properties re-sensitizes chemotherapy resistant cancer. PLoS ONE. 2019;14:e0218125. doi: 10.1371/journal.pone.0218125.", "ArticleIdList": ["10.1371/journal.pone.0218125", "PMC6559640", "31185048"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Taylor W.F., Jabbarzadeh E. The use of natural products to target cancer stem cells. Am. J. Cancer Res. 2017;7:1588\u20131605.", "ArticleIdList": ["PMC5523038", "28744407"]}, {"Citation": "Yanez M., Jhanji M., Murphy K., Gower R.M., Sajish M., Jabbarzadeh E. Nicotinamide Augments the Anti-Inflammatory Properties of Resveratrol through PARP1 Activation. Sci. Rep. 2019;9:10219. doi: 10.1038/s41598-019-46678-8.", "ArticleIdList": ["10.1038/s41598-019-46678-8", "PMC6629694", "31308445"]}, {"Citation": "Yanez M., Blanchette J., Jabbarzadeh E. Modulation of Inflammatory Response to Implanted Biomaterials Using Natural Compounds. Curr. Pharm. Des. 2017;23:6347\u20136357. doi: 10.2174/1381612823666170510124348.", "ArticleIdList": ["10.2174/1381612823666170510124348", "PMC5681444", "28521709"]}, {"Citation": "Huang Y., Cai T., Xia X., Cai Y., Wu X.Y. Research Advances in the Intervention of Inflammation and Cancer by Active Ingredients of Traditional Chinese Medicine. J. Pharm. Pharm. Sci. 2016;19:114\u2013126. doi: 10.18433/J3SG7K.", "ArticleIdList": ["10.18433/J3SG7K", "27096696"]}, {"Citation": "Li L., Hou X., Xu R., Liu C., Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam. Clin. Pharmacol. 2017;31:17\u201336. doi: 10.1111/fcp.12232.", "ArticleIdList": ["10.1111/fcp.12232", "27567103"]}, {"Citation": "Auyeung K.K., Mok N.L., Wong C.M., Cho C.H., Ko J.K. Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. Int. J. Mol. Med. 2010;26:341\u2013349.", "ArticleIdList": ["20664949"]}, {"Citation": "Troselj K.G., Kujundzic R.N. Curcumin in combined cancer therapy. Curr. Pharm. Des. 2014;20:6682\u20136696. doi: 10.2174/1381612820666140826154601.", "ArticleIdList": ["10.2174/1381612820666140826154601", "25341940"]}, {"Citation": "Iwanowycz S., Wang J., Hodge J., Wang Y., Yu F., Fan D. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages. Mol. Cancer Ther. 2016;15:1931\u20131942. doi: 10.1158/1535-7163.MCT-15-0987.", "ArticleIdList": ["10.1158/1535-7163.MCT-15-0987", "PMC4975665", "27196773"]}, {"Citation": "Wang Y., Yu H., Zhang J., Ge X., Gao J., Zhang Y., Lou G. Anti-tumor effect of emodin on gynecological cancer cells. Cell. Oncol. (Dordr) 2015;38:353\u2013363. doi: 10.1007/s13402-015-0234-8.", "ArticleIdList": ["10.1007/s13402-015-0234-8", "26162964"]}, {"Citation": "Yu G.J., Choi I.W., Kim G.Y., Kim B.W., Park C., Hong S.H., Moon S.K., Cha H.J., Chang Y.C., Paek K.Y., et al. Anti-inflammatory potential of saponins derived from cultured wild ginseng roots in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int. J. Mol. Med. 2015;35:1690\u20131698.", "ArticleIdList": ["25847675"]}, {"Citation": "Zhang X., Zhang S., Sun Q., Jiao W., Yan Y. Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3. Molecules. 2018;23:1482. doi: 10.3390/molecules23061482.", "ArticleIdList": ["10.3390/molecules23061482", "PMC6099685", "29921768"]}, {"Citation": "Castro A.P., Kawano T., Spelta L.E.W., de Castro A.T., Pereira N.A., Couto F.F.B., Dos Santos M.H., Boralli V.B., Marques M.J. In vivo schistosomicidal activity of 7-epiclusianone and its quantification in the plasma of healthy and Schistosoma mansoni infected mice using UPLC-MS/MS. Phytomedicine. 2018;38:66\u201373. doi: 10.1016/j.phymed.2017.11.001.", "ArticleIdList": ["10.1016/j.phymed.2017.11.001", "29425656"]}, {"Citation": "Almeida L.S., Murata R.M., Yatsuda R., Dos Santos M.H., Nagem T.J., Alencar S.M., Koo H., Rosalen P.L. Antimicrobial activity of Rheedia brasiliensis and 7-epiclusianone against Streptococcus mutans. Phytomedicine. 2008;15:886\u2013891. doi: 10.1016/j.phymed.2007.12.003.", "ArticleIdList": ["10.1016/j.phymed.2007.12.003", "18276126"]}, {"Citation": "de Barros M., Perciano P.G., Dos Santos M.H., De Oliveira L.L., Costa \u00c9., Moreira M.A.S. Antibacterial Activity of 7-Epiclusianone and Its Novel Copper Metal Complex on Streptococcus spp. Isolated from Bovine Mastitis and Their Cytotoxicity in MAC-T Cells. Molecules. 2017;22:823. doi: 10.3390/molecules22050823.", "ArticleIdList": ["10.3390/molecules22050823", "PMC6154111", "28513553"]}, {"Citation": "Santa-Cec\u00edlia F.V., Freitas L.A., Vilela F.C., Veloso C.E.C., da Rocha C.Q., Moreira M.E., Dias D.F., Giusti-Paiva A., dos Santos M.H. Antinociceptive and anti-inflammatory properties of 7-epiclusianone, a prenylated benzophenone from Garcinia brasiliensis. Eur. J. Pharmacol. 2011;670:280\u2013285. doi: 10.1016/j.ejphar.2011.08.032.", "ArticleIdList": ["10.1016/j.ejphar.2011.08.032", "21924261"]}, {"Citation": "Murata R.M., Yatsuda R., dos Santos M.H., Kohn L.K., Martins F.T., Nagem T.J., Alencar S.M., de Carvalho J.E., Rosalen P.L. Antiproliferative effect of benzophenones and their influence on cathepsin activity. Phytother. Res. 2010;24:379\u2013383. doi: 10.1002/ptr.2954.", "ArticleIdList": ["10.1002/ptr.2954", "19653314"]}, {"Citation": "Simpkins N.S., Holtrup F., Rodeschini V., Taylor J.D., Wolf R. Comparison of the cytotoxic effects of enantiopure PPAPs, including nemorosone and clusianone. Bioorg. Med. Chem. Lett. 2012;22:6144\u20136147. doi: 10.1016/j.bmcl.2012.08.023.", "ArticleIdList": ["10.1016/j.bmcl.2012.08.023", "22944119"]}, {"Citation": "Sales L., Pezuk J.A., Borges K.S., Brassesco M.S., Scrideli C.A., Tone L.G., dos Santos M.H., Ionta M., de Oliveira J.C. Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma. BMC. Complement. Altern. Med. 2015;15:393. doi: 10.1186/s12906-015-0911-1.", "ArticleIdList": ["10.1186/s12906-015-0911-1", "PMC4628319", "26518729"]}, {"Citation": "Ionta M., Ferreira-Silva G.A., Niero E.L., Costa \u00c9., Martens A.A., Rosa W., Soares M.G., Machado-Santelli G.M., Lago J.H., Santos M.H. 7-Epiclusianone, a Benzophenone Extracted from Garcinia brasiliensis (Clusiaceae), Induces Cell Cycle Arrest in G1/S Transition in A549 Cells. Molecules. 2015;20:12804\u201312816. doi: 10.3390/molecules200712804.", "ArticleIdList": ["10.3390/molecules200712804", "PMC6332126", "26184153"]}, {"Citation": "Reis F.H., Pardo-Andreu G.L., Nu\u00f1ez-Figueredo Y., Cuesta-Rubio O., Mar\u00edn-Prida J., Uyemura S.A., Curti C., Alberici L.C. Clusianone, a naturally occurring nemorosone regioisomer, uncouples rat liver mitochondria and induces HepG2 cell death. Chem. Biol. Interact. 2014;212:20\u201329. doi: 10.1016/j.cbi.2014.01.015.", "ArticleIdList": ["10.1016/j.cbi.2014.01.015", "24491676"]}, {"Citation": "Boyce J.H., Porco J.A. Asymmetric, stereodivergent synthesis of (-)-clusianone utilizing a biomimetic cationic cyclization. Angew. Chem. Int. Ed. Engl. 2014;53:7832\u20137837. doi: 10.1002/anie.201404437.", "ArticleIdList": ["10.1002/anie.201404437", "PMC4182949", "24916169"]}, {"Citation": "Horwitz S.B. Taxol (paclitaxel): Mechanisms of action. Ann. Oncol. 1994;5:S3\u2013S6.", "ArticleIdList": ["7865431"]}, {"Citation": "Va\u0161\u00edkov\u00e1 A. [EML4-ALK fusion gene in patients with lung carcinoma: Biology, diagnostics and targeted therapy] Klin. Onkol. 2012;25:434\u2013439.", "ArticleIdList": ["23301645"]}, {"Citation": "Malemud C.J. The role of the JAK/STAT signal pathway in rheumatoid arthritis. Ther. Adv. Musculoskelet. Dis. 2018;10:117\u2013127. doi: 10.1177/1759720X18776224.", "ArticleIdList": ["10.1177/1759720X18776224", "PMC6009092", "29942363"]}, {"Citation": "Simbulan-Rosenthal C.M., Rosenthal D.S., Iyer S., Boulares H., Smulson M.E. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol. Cell. Biochem. 1999;193:137\u2013148. doi: 10.1023/A:1006988832729.", "ArticleIdList": ["10.1023/A:1006988832729", "10331650"]}, {"Citation": "Ghobrial I.M., Witzig T.E., Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005;55:178\u2013194. doi: 10.3322/canjclin.55.3.178.", "ArticleIdList": ["10.3322/canjclin.55.3.178", "15890640"]}, {"Citation": "Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002;29:15\u201318. doi: 10.1053/sonc.2002.37263.", "ArticleIdList": ["10.1053/sonc.2002.37263", "12516034"]}, {"Citation": "Moghadam S.E., Ebrahimi S.N., Salehi P., Moridi Farimani M., Hamburger M., Jabbarzadeh E. Wound Healing Potential of Chlorogenic Acid and Myricetin-3-O-\u03b2-Rhamnoside Isolated from Parrotia persica. Molecules. 2017;22:1501. doi: 10.3390/molecules22091501.", "ArticleIdList": ["10.3390/molecules22091501", "PMC5603238", "28885580"]}, {"Citation": "Harris G.M., Rutledge K., Cheng Q., Blanchette J., Jabbarzadeh E. Strategies to direct angiogenesis within scaffolds for bone tissue engineering. Curr. Pharm. Des. 2013;19:3456\u20133465. doi: 10.2174/1381612811319190011.", "ArticleIdList": ["10.2174/1381612811319190011", "23432671"]}, {"Citation": "Somasundaram A., Burns T.F. The next generation of immunotherapy: Keeping lung cancer in check. J. Hematol. Oncol. 2017;10:87. doi: 10.1186/s13045-017-0456-5.", "ArticleIdList": ["10.1186/s13045-017-0456-5", "PMC5402056", "28434399"]}, {"Citation": "Jinushi M., Komohara Y. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside. Biochim. Biophys. Acta. 2015;1855:123\u2013130. doi: 10.1016/j.bbcan.2015.01.002.", "ArticleIdList": ["10.1016/j.bbcan.2015.01.002", "25595840"]}, {"Citation": "Brown J.M., Recht L., Strober S. The Promise of Targeting Macrophages in Cancer Therapy. Clin. Cancer Res. 2017;23:3241\u20133250. doi: 10.1158/1078-0432.CCR-16-3122.", "ArticleIdList": ["10.1158/1078-0432.CCR-16-3122", "PMC5529121", "28341752"]}, {"Citation": "Piccinelli A.L., Cuesta-Rubio O., Barrios Chica M., Mahmood N., Pagano B., Pavone M., Barone V., Rastrelli L. Structural revision of clusianone and 7-epi-clusianone and anti-HIV activity of polyisoprenylated benzophenones. Tetrahedron. 2005;61:8206\u20138211. doi: 10.1016/j.tet.2005.06.030.", "ArticleIdList": ["10.1016/j.tet.2005.06.030"]}, {"Citation": "NCI-60 Human Tumor Cell Lines Screen.  [(accessed on 4 December 2017)]; Available online:  https://dtp.cancer.gov/discovery_development/nci-60/"}, {"Citation": "Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer. 2006;6:813\u2013823. doi: 10.1038/nrc1951.", "ArticleIdList": ["10.1038/nrc1951", "16990858"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "25"}, {"Year": "2019", "Month": "11", "Day": "30"}, {"Year": "2019", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["31816878", "PMC6930650", "10.3390/molecules24234415", "molecules24234415"]}}]}